Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.0 TWD
382.62 M TWD
469.27 M TWD
25.16 M
About ALAR PHARMACEUTICALS INC
Sector
CEO
Yung Shun Wen
Headquarters
Taichung
Website
Founded
2016
ISIN
TW0006785009
FIGI
BBG00XKGF2B6
Alar Pharmaceuticals, Inc. engages in the development of long-acting release drug products for CNS disorders and chronic diseases. It develops drugs for opioid use disorder, chronic pain, and major depressive disorder. The company was founded on September 23, 2016 and is headquartered in Taichung, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6785 is 137.0 TWD — it has decreased by −1.08% in the past 24 hours. Watch ALAR PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange ALAR PHARMACEUTICALS INC stocks are traded under the ticker 6785.
6785 stock has fallen by −8.05% compared to the previous week, the month change is a −9.57% fall, over the last year ALAR PHARMACEUTICALS INC has showed a −36.13% decrease.
We've gathered analysts' opinions on ALAR PHARMACEUTICALS INC future price: according to them, 6785 price has a max estimate of 290.00 TWD and a min estimate of 290.00 TWD. Watch 6785 chart and read a more detailed ALAR PHARMACEUTICALS INC stock forecast: see what analysts think of ALAR PHARMACEUTICALS INC and suggest that you do with its stocks.
6785 reached its all-time high on Feb 21, 2024 with the price of 465.0 TWD, and its all-time low was 43.0 TWD and was reached on Jan 21, 2022. View more price dynamics on 6785 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6785 stock is 2.56% volatile and has beta coefficient of 0.19. Track ALAR PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is ALAR PHARMACEUTICALS INC there?
Yes, you can track ALAR PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
ALAR PHARMACEUTICALS INC is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
6785 net income for the last quarter is −15.22 M TWD, while the quarter before that showed −3.54 M TWD of net income which accounts for −329.52% change. Track more ALAR PHARMACEUTICALS INC financial stats to get the full picture.
Yes, 6785 dividends are paid annually. The last dividend per share was 1.50 TWD. As of today, Dividend Yield (TTM)% is 1.09%. Tracking ALAR PHARMACEUTICALS INC dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALAR PHARMACEUTICALS INC EBITDA is 389.51 M TWD, and current EBITDA margin is 82.87%. See more stats in ALAR PHARMACEUTICALS INC financial statements.
Like other stocks, 6785 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALAR PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALAR PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALAR PHARMACEUTICALS INC stock shows the sell signal. See more of ALAR PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.